Table 4 Outcomes of studies of PFMT with percentage cure, cure/improvement and positive and statistically significant outcomes
PFMT studies | Treatment time | N (subjects) | N (% lost to follow-up) | % cure | % cure/improved | N (%) positive & statistically significant outcomes |
|---|---|---|---|---|---|---|
Bo (1999) | 6 months | 29 | 4 (14) | 44 (1), 56 (4) | 48 (4) | 8/9 (89) |
Morkved (2002) | 6 months | 50 | 4 (17) | 46 (1), 30 (4) 57 (2) | 93 (4) | 6 (100) |
Bo (2000) | 6 months | 24 | 4 (8) | 6–44 (5) | NR | 1 (100) |
Berghmans (1996) | 4 weeks | 20 | 0 (0) | 15 (2) | 85 (2) | 1 (100) |
Miller (1998b) | 1 week | 27 | 0 (0) | 23 (3) | NR | 2 (100) |
Hay-Smith (2002)a | 20 weeks | 64 | 2 (3) | 7 (4) | 47 (4) | NR |
Hay-Smith (2002)b | 20 weeks | 64 | 3 (5) | 2 (4) | 41 (4) | NR |
Arvonen (2001) | 4 months | 20 | 1 (5) | 26 (1) | 58 (4) | 3 (100) |
Glavind (1996) | NR (2–3 sessions) | 20 | 5 (25) | 20 (1) | NR | NR |
Pages (2001) | 3 months | 27 | 0 (0) | 69 (4) | 100 (4) | 3 (100) |
Bidmead (2002) | 14 weeks | 40 | NR | NR | NR | 3 (100) |
Sung (2000) | 6 weeks | 30 | NR | NR | NR | 3 (100) |
Aksac (2003) | 8 weeks | 20 | NR | 75 (3) | 100 (3) | 10 (100) |
Finkenhagen (1998) | 6 months | 38 | 2 (5) | 35 (4) | 71 (4) | NR |